Refine by
Clinical Sample Articles & Analysis
37 news found
"Our See.d instrument prepares high-quality samples, ensuring precise measurement of both cellular and cell-free tumor markers in blood. ...
The service provides a comprehensive overview of all viral genetic material present in a sample, enabling the detection of both known and previously unknown viruses in a single assay. The Viral Metagenomic Sequencing service is designed to accommodate various sample types, including clinical samples, environmental ...
“We now regard the industrialization of microsphere products as the main development goal and offer microsphere products at a production scale that can be scaled up linearly. The batch size of key clinical study samples should be consistent with the commercial production batch size,” said the Marketing Director of CD Formulation. ...
BAY 2927088 is a reversible small molecule inhibitor that is currently being evaluated in a first-in-human, Phase 1 clinical trial in non-small cell lung cancer (NSCLC) patients with mutations in epidermal growth factor receptors (EGFR & HER2) including exon20 insertions and point mutations. For the first time, Bayer will present the design of the clinical ...
ByBayer AG
So far, the program, has analyzed 15 patients demonstrating the potential of the approach and highlighting the following benefits when compared with short-read sequencing; Significantly faster turnaround times of under three days from sample collection to clinical report versus 3-4 week turnaround using outsourced short read sequencing Reliable detection of ...
To see video, please click here In this free webinar you will learn about: Guide to Sample Size Re-estimation in Clinical Trials Unblinded Sample Size Re-estimation Sample Size for Complex Endpoints Sample Size for Win Ratio Statistic Sample Size for Win Ratio Statistic Block ...
ByStatsol
About the webinar We explore common challenges faced when designing and conducting clinical trials with sample size re-estimation (SSR). Common SSR methods are explored along with their pros and cons. ...
ByStatsol
(PRWEB) January 19, 2018 — Entegrion, Inc. today announced that it has achieved CE mark for the Company’s portable coagulation monitoring system (“PCM”) for use in clinical settings for the viscoelastic measurement of patient whole blood coagulation and hemostasis. ...
About the webinar In this webinar, we explored some of the issues faced when statistical power is used as the sole metric for trial success when conducting a sample size determination. We showed how Bayesian assurance can be used as a complementary metric, that allows parameter uncertainty to be formally incorporated into the trial design. ...
ByStatsol
Vault Health’s decentralized research capabilities will allow Faeth to extend the NEAAR clinical trial beyond physical clinical trial sites to patients living across the country. By combining xCures’ records collection, virtual screening, eConsent and data structuring technology with Vault Health’s state-of-the-art suite of patient-centric ...
ByxCures
” A primary focus of the study was to obtain a deeper understanding of the tumor microenvironment similarities and/or differences that may lead to IL-2 or anti-PD-(L)1 therapy response. Retrospective tumor samples and corresponding clinical response data were collected from patients with a primary diagnosis of RCC who were treated with high-dose IL-2 ...
Random sampling stratified by clinical factors was used to split the data into independent training (N=140) and validation (N=131) subsets. Multivariant Cox Proportional Hazard (PH) and Proportional Odds models were used to predict survival and pathological response as a function of the pre-defined Therapy Response Index (TRI) and clinical ...
“The Miro Canvas offers a truly ‘walk away’ solution for complex NGS workflows without the need to batch samples together.” Interpace Diagnostics will utilize Twist Bioscience’s chemistries for library preparation and hybridization capture for the automation of Interpace’s custom NGS panels, and Miroculus’s DMF instrument, the Miro ...
“While our work has expanded well beyond the lung, the actionable clinical and genomic datasets we have developed have led to multiple signatures and related prototype tests. ...
Specific Diagnostics today announced formation of its US commercial sales, service, support and marketing teams in anticipation of the launch of the Reveal Rapid AST System for blood infection samples. Following 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.8%, ...
Concurrently, INOVIO has initiated pre-clinical development of an Omicron-specific DNA vaccine candidate and will progress if needed. ...
Comparing the differential changes in the expression of a large number of proteins in different normal and tumor samples or samples under different treatment conditions. 2. Large-scale analysis of post-translational modification sites in proteins and the changes in protein modification levels under different conditions. 3. ...
The study, titled “Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Haematological Cancers and Identifies Exceptional Responders,” illustrates the potential real-world impact of using Exscientia’s AI-supported precision medicine platform (referred to in the study as single-cell functional precision medicine or scFPM) to propose ...
In Europe, where the Reveal is launched under CE-IVD registration, 11 studies across France and England comprising over 1,400 clinical positive blood culture samples, yielding overall accuracy of 97.6% have been completed, with 4 of these studies now reported by submitted abstracts, complementing the similar results reported by Henry Ford Health System in ...
The team at Indee Labs has already demonstrated revolutionary improvements over existing methods including scalability, high yield, negligible perturbation of the immune cell state along with rapid processing of research-, clinical- and commercial-scale samples with a simple workflow and a small footprint. ...